Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
American Journal of Clinical Dermatology|June 23, 2019
Intratumoral and Combination Therapy in Melanoma and Other Skin CancersArielle Oglesby, Alain P Algazi, Adil I DaudNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Biology and treatment of primary central nervous system lymphomaAlain P Algazi, Cigall Kadoch, James L RubensteinCancer Management and Research|December 29, 2010
Treatment of cutaneous melanoma: current approaches and future prospectsAlain P Algazi, Christopher W Soon, Adil I DaudHead & Neck|November 24, 2023
Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neckAudrey Humphries, Connie J Zhou, Madeleine Welsh, et al.Journal for Immunotherapy of Cancer|September 24, 2016
Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockadeKaty K Tsai, Miguel H Pampaloni, Charity Hope, et al.Pigment Cell & Melanoma Research|September 19, 2017
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanomaAlain P Algazi, Rosaura Esteve-Puig, Adi Nosrati, et al.Head & Neck|January 12, 2019
Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary siteJason W Chan, Iwei Yeh, Ivan H El-Sayed, et al.Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|April 27, 2018
Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinomaMelody J Xu, Tara J Wu, Annemieke van Zante, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced CancerLee S Rosen, Jonathan W Goldman, Alain P Algazi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2024
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell CarcinomaChristopher A Barker, Suzanne Dufault, Sarah T Arron, et al.Pageof 5